Markt für Hilfsmittel zur Raucherentwöhnung – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPRE00023325
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 156
Buy Now

Der Markt für Hilfsmittel zur Raucherentwöhnung wird im Jahr 2028 voraussichtlich 64.032,30 Millionen US-Dollar erreichen, gegenüber 23.413,08 Millionen US-Dollar im Jahr 2021. Es wird geschätzt, dass der Markt von 2021 bis 2028 mit einer jährlichen Wachstumsrate von 15,5 % wächst.



Schlüsselfaktoren, die das Wachstum dieses Marktes vorantreiben, sind die zunehmende Abhängigkeit vom Tabakrauchen sowie die zunehmende Zahl von Kampagnen zur Reduzierung des Rauchens und der Tabakabhängigkeit. Allerdings dürften die steigenden Kosten für die Entwicklung von Nikotinersatztherapien das Marktwachstum in den kommenden Jahren in gewissem Maße bremsen.



Lukrative Regionen für den Markt für Hilfsmittel zur Raucherentwöhnung



Markteinblicke

Steigende Sucht nach Tabakrauchen



Nikotin ist eine stark süchtig machende Substanz, die in der Tabakpflanze vorkommt. Das Rauchen von Tabak hat sich in jeder Form als gefährlich erwiesen, da es zu chronischen Gesundheitsproblemen, vermeidbaren Krankheiten, Todesfällen und Behinderungen führen kann. Nach Angaben der Weltgesundheitsorganisation (WHO) führen rauchbedingte Erkrankungen in den USA zu etwa 435.000 Todesfällen pro Jahr, was etwa einem Fünftel aller Todesfälle im Land entspricht. Nach Angaben der Centers of Disease Control and Prevention (CDC) rauchten im Jahr 2018 fast 40 Millionen Erwachsene in den USA Zigaretten. Darüber hinaus konsumierten etwa 4,7 Millionen Schüler der Mittel- und Oberstufe mindestens ein Tabakprodukt und etwa 1.600 junge Menschen unter 18 Jahren in den USA rauchten ihre ersten Zigaretten. Jedes Jahr sterben fast eine halbe Million Patienten an den Folgen einer durch das Rauchen verursachten Krankheit. Die US-Regierung gibt etwa 225 Milliarden US-Dollar für die medizinische Versorgung von Patienten aus, die in den USA an rauchbedingten Erkrankungen leiden. Daher ist die Prävalenz des Tabakrauchens in verschiedenen Ländern der Welt hoch. In verschiedenen europäischen und asiatischen Ländern ist die Situation ähnlich. Griechenland, Bulgarien, Frankreich und Kroatien bilden die Bevölkerungsgruppen mit hohem Tabakkonsum in Europa. Nach Angaben des Institute of Health Metrics and Evaluation ist Rauchen in Europa eine weit verbreitete Sucht, da über 20 % der Erwachsenen über 15 Jahren täglich rauchen. Darüber hinaus sind laut World Population Review die höchsten Raucherquoten in Südostasien und auf dem Balkan in Europa zu verzeichnen. Das WPR weist außerdem darauf hin, dass in verschiedenen süd- und südostasiatischen Ländern die Raucherquote bei Männern tendenziell hoch ist. In Indonesien beispielsweise lag die Raucherquote unter Männern im Jahr 2018 bei 76,20 %. Somit treibt die steigende Zahl der Raucher weltweit das Wachstum des globalen Marktes für Hilfsmittel zur Raucherentwöhnung voran.



Produktbasierte Erkenntnisse



Je nach Produkt ist der Markt für Hilfsmittel zur Raucherentwöhnung in Nikotinersatztherapie, Medikamente, elektronische Zigaretten und andere unterteilt. E-Zigaretten gelten als gesunde Alternative zu Tabakzigaretten und dürften im Prognosezeitraum das am schnellsten wachsende Segment sein. E-Zigaretten sind eine wirksame Alternative zur Linderung der mit Tabak verbundenen Gesundheitsprobleme, während Nikotinersatztherapien am besten zur Raucherentwöhnung geeignet sind. E-Zigaretten stellen eine potenzielle Bedrohung für Tabakzigaretten dar. Darüber hinaus ist der Konsum von E-Zigaretten im Vergleich zu herkömmlichen Zigaretten weniger schädlich, kein Rauch und keine Gefahr des Passivrauchens, die Verwendung ist auch an Nichtraucherorten erlaubt, unterschiedliche Nikotinwerte und die Verfügbarkeit in verschiedenen Geschmacksrichtungen sind einige der wichtigsten Vorteile treibende Faktoren für den E-Zigaretten-Markt. Darüber hinaus ist die zunehmende Beliebtheit von E-Zigaretten aufgrund ihrer elektronischen Funktion der Hauptfaktor für die steigende Nachfrage.



Markt für Hilfsmittel zur Raucherentwöhnung, nach Produkt – 2021 und 2028



Endbenutzerbasierte Erkenntnisse



Basierend auf dem Endbenutzer ist der Markt für Hilfsmittel zur Raucherentwöhnung in Krankenhausapotheken, Online-Vertriebsapotheken, Einzelhandelsapotheken und andere Endbenutzer unterteilt. Das Segment der Einzelhandelsapotheken dürfte im Jahr 2021 den größten Marktanteil halten, allerdings wird erwartet, dass das Segment der Online-Vertriebskanäle im Prognosezeitraum die höchste CAGR des Marktes verzeichnen wird.



Strategische Einblicke



Die wichtigsten Akteure wie Pfizer Inc.; GlaxoSmithKline plc.; Dr. Reddys Laboratorien; Johnson und Johnson Services, Inc.; Cipla Inc.; Perrigo Company plc; Bausch Health Companies Inc.; Glenmark; Viel Freude; und Juul Labs verfolgen mehrere organische und anorganische Strategien, um ihren Umsatz und ihre Marktposition zu verbessern. Beispielsweise brachte Dr. Reddy’s Laboratories im Juli 2020 rezeptfreie Nikotin-Polacrilex-Lutschtabletten in den Stärken 2 mg und 4 mg auf den amerikanischen Markt. Darüber hinaus schloss die Perrigo Company plc im November 2020 das vierte Jahr ihrer Kampagne „Aufhören ist besser“ in Zusammenarbeit mit der American Cancer Society (ACS) ab.



Markt für Hilfsmittel zur Raucherentwöhnung – nach Produkt


  • Nikotinersatztherapie

  • Medikamente

  • Elektronische Zigaretten

  • Andere


Markt für Hilfsmittel zur Raucherentwöhnung - nach Endbenutzer




  • Krankenhausapotheken

  • Online-Kanal

  • Einzelhandelsapotheken

  • Andere


Markt für Hilfsmittel zur Raucherentwöhnung – nach Geografie




  • Nordamerika
    • USA

    • Kanada

    • Mexiko

    • < /ul>
    • Europa
      • Frankreich

      • Deutschland

      • Italien

      • Großbritannien

      • Spanien

      • Restliches Europa



    • Asien-Pazifik (APAC)
      • China

      • Indien

      • < li>Japan
      • Australien

      • Südkorea

      • Übriger Asien-Pazifik-Raum



    • Naher Osten und Afrika (MEA)
      • Südafrika

      • Saudi-Arabien

      • VAE

      • Übriger Naher Osten und Afrika


    • Süd- und Mittelamerika (SCAM)
      • Brasilien

      • Argentinien

      • Übriges Süd- und Mittelamerika



    Unternehmensprofile




    • Pfizer Inc.

    • GlaxoSmithKline plc.

    • Dr. Reddy's Laboratories

    • Johnson and Johnson Services, Inc.

    • Cipla Inc.

    • Perrigo Company plc

    • Bausch Health Companies Inc.
    • Glenmark

    • NJOY

    • Juul Labs


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is Smoking cessation?

Smoking cessation lowers the risk of cancer and other serious health problems. Some products contain nicotine as an active ingredient and others do not. Counseling, behavior therapy, medicines, and nicotine-containing products, such as nicotine patches, gum, lozenges, inhalers, and nasal sprays, may be used to help a person quit smoking.

Who are the major players in the Smoking Cessation Aids Market?

The Smoking Cessation Aids Market majorly consists of the players such as Pfizer Inc., GlaxoSmithKline plc., Dr. Reddy's Laboratories, Johnson and Johnson Services, Inc., Cipla Inc., Perrigo Company plc, Bausch Health Companies Inc., Glenmark, NJOY, Juul Labs among others amongst others.

Which country has dominated the Smoking Cessation Aids Market?

The US is the largest market for Smoking Cessation Aids at a global level. The market's growth is attributed to the Increasing implementation of various tobacco control programs, high expenditure in healthcare and wellness by the countries in the region and launch of new and innovative products by market players for smoking cessation are some of the factors likely to drive the Smoking Cessation Aids market in the region. According to CDC, in 2017, 14 of every 100 US adults aged 18 years or older (14.0%) currently smoke cigarettes. This hints at a high usage of de-addiction products. Also, this depicts the growing awareness of the people and their readiness to quit smoking. There are also non-government and government establishments working to educate and help people quit smoking that is engaged dedicatedly, to bring the number of smokers down.

Which region is the fastest growing the Smoking Cessation Aids Market?

Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to increasing awareness about the smoking cessation and nicotine de-addiction products, and a huge population base in the region. For instance, an international collaboration of researchers, led by those from Vanderbilt University in the United States, studied the trends in tobacco use in China, Japan, South Korea, Singapore, Taiwan, and India in Tobacco Smoking and Mortality in Asia, a pooled meta-analysis published by JAMA Network in March 2019. By 2030, it is anticipated that 8.3 million fatalities would be due to smoking. China, India, and Indonesia account for half of the world's male smokers, and Asia is the world's largest tobacco user and production.

Which segment is dominating the Smoking Cessation Aids Market?

The global Smoking Cessation Aids market based on product is segmented into nicotine replacement therapy, drugs, electronic cigarettes, and others. In 2021, the electronic cigarettes segment held the largest share of the market, by product. The electronic cigarettes segment of Smoking Cessation Aids Market is also expected to witness fastest CAGR during 2021 to 2028.The increasing number of campaigns to reduce smoking and tobacco dependence are likely to increase the demand for the above-mentioned products. Therefore, it is expected that market is likely to propel during the forecast period.

What are the driving factors for the Smoking Cessation Aids Market across the globe?

The factors that are driving and restraining factors that will affect Smoking Cessation Aids Market in the coming years. Factors such as rising addiction toward tobacco smoking, increasing number of campaigns to reduce smoking and tobacco dependence. However, steeping costs for development of nicotine replacement therapies are likely to restrain the market growth in the future years to some extent.

The List of Companies - Smoking Cessation Aids Market

  1. Pfizer Inc.
  2. GlaxoSmithKline plc.
  3. Dr. Reddy's Laboratories
  4. Johnson and Johnson Services, Inc.
  5. Cipla Inc.
  6. Perrigo Company plc
  7. Bausch Health Companies Inc.
  8. Glenmark
  9. NJOY
  10. Juul Labs

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports